Literature DB >> 3121728

Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.

L Chen1, Y Suzuki, E F Wheelock.   

Abstract

Small concentrations of recombinant murine interferon-gamma (MuIFN-gamma), recombinant human interleukin 1 (HuIL-1), and recombinant murine tumor necrosis factor (MuTNF), added separately to cultures of thioglycolate-elicited peritoneal macrophages, produced no cytotoxic activity against L5178Y cells, a tumor cell line which is resistant to the direct toxic effects of these cytokines, either alone or in combination. However, small concentrations of MuIFN-gamma when combined with small concentrations of either HuIL-1 or MuTNF activated these macrophages to produce cytotoxic effects against L5178Y cells; small concentrations of HuIL-1 and MuTNF in combination had no macrophage activating activity. Specific antibody to MuTNF blocked the macrophage-activating synergistic effects of MuIFN-gamma + HuIL-1, and specific antibody to HuIL-1 blocked the macrophage-activating activity of MuIFN-gamma + MuTNF, indicating that MuTNF was induced in macrophage cultures treated with MuIFN-gamma + HuIL-1, and that murine IL-1 was induced in macrophage cultures treated with MuIFN-gamma + MuTNF. These results indicate that all three cytokines are required for induction of antitumor cytotoxic activation of macrophages. Experiments with a concentration of MuIFN-gamma which alone could activate macrophages revealed that both MuTNF and murine IL-1 were required for this activation. The demonstration that small concentrations of these three cytokines can act synergistically, but not separately, to activate macrophages indicates the importance of cytokine combinations in immunoregulation and in anti-tumor cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens.

Authors:  S E Valone; E A Rich; R S Wallis; J J Ellner
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Activated monocytes kill malignant brain tumor cells in vitro.

Authors:  M Kirsch; H Fischer; G Schackert
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Authors:  R Beyaert; C De Potter; B Vanhaesebroeck; F Van Roy; W Fiers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

4.  Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.

Authors:  T Hibi; M Ohara; M Watanabe; T Kanai; H Takaishi; A Hayashi; Y Hosoda; H Ogata; Y Iwao; S Aiso
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

5.  Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation.

Authors:  K Suk; S D Somers; K L Erickson
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

6.  Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

Authors:  R H Widen; C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Effects of cytokines on intracellular growth of Brucella abortus.

Authors:  X Jiang; C L Baldwin
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-gamma combined with a lipid A subunit analog (GLA-60) of low toxicity.

Authors:  I Saiki; H Maeda; T Sakurai; J Murata; J Iida; M Kiso; A Hasegawa; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.

Authors:  R E Garner; U Kuruganti; C W Czarniecki; H H Chiu; J E Domer
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.

Authors:  W Lasek; A Wańkowicz; K Kuc; W Feleszko; J Gołab; A Giermasz; W Wiktor-Jedrzejczak; M Jakóbisiak
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.